Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Gabapentin in Treating Pain in Children With Severe Neurological Impairment

NCT04619862 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT04619862
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04619862 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Gabapentin in Treating Pain in Children With Severe Neurological Impairment
Lead sponsor
University of British Columbia
Phase
Phase 2
Overall status
Unknown status
Start date
May 15, 2021
Completion date
April 30, 2026
Enrollment
5 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

irritability, neuropathic pain, pain